Kevin Bowling

Senior Scientist


Kevin Bowling received his Ph.D. in Molecular Biology/Biochemistry from the University of Alabama. He joined HudsonAlpha in 2009 and is utilizing a number of genomic techniques to better understand molecular pathologies that underlie neurological phenotypes. Kevin’s current studies focus on detecting DNA methylation and gene expression signatures that associate with bipolar disorder, major depression, schizophrenia and Parkinson disease.